Work

前立腺肥大症に伴う下部尿路症状に対するナフトピジルの長期投与の臨床的検討 - 国際前立腺症状スコア(ipss)の変化, 閉塞症状, 膀胱刺激症状, 夜間頻尿および残尿量に関する検討 -

Year: 2003
Type: article
Study design: Clinical Trial
Abstract: Naftopidil was administered to 67 patients with benign prostatic hyperplasia (BPH) for 12 months. Changes in total/each International Prostate Symptom Score (IPSS) for irritative and obstructive symptoms, nocturia, and residual urine volume were compared before and after its administration. As a result, a significant decrease of score was found in total-IPSS, obstructive and irritative symptoms, which also showed a tendency to decrease at the end of the first month. Nocturia and residual urine volume also significantly decreased after its administration. Naftopidil is considered to be effective in the treatment of BPH, especially irritative symptoms including nocturia in treatments for BPH, because both irritative and obstructive symptoms (IPSS subjective endpoints) and residual urine volume (objective endpoint) were improved after its long-term administration.
Language: Japanese
Subfield: Urology
Field: Medicine
Open Access status: green
OpenAlex ID: W7208042553
FWCI:
Cites:
Cited by:
Related to: 10